iBeta certifies Lumidigm fingerprint readers for DEA EPCS

iBeta Quality Assurance has just completed one of the first DEA EPCS biometric certifications for a series of Lumidigm fingerprint readers that can now be used in EPCS systems by prescribers of controlled substances.

Specifically, iBeta certified Lumidigm’s V-Series fingerprint readers, finding that when properly incorporated into an overall prescribing system, these readers meet the required false match rate of 0.001.

“The Lumidigm devices not only meet the DEA false match rate regulation, we encountered no failures to enroll during the certification test effort,” Kevin Wilson, Principle Investigator on the Lumidigm certification project said.

The full certification report is available from the iBeta Biometrics website.

Reported previously, iBeta also recently completed conformance testing of mobile biometric devices, under a contract from Sandia National Laboratories for the Department of Homeland Security.

Recently, Lumidigm announced its technology is now being used as a part of the Republic of Korea’s immigration clearance process.

In addition to the ports in Korea, Lumidigm’s multispectral readers are also being used at the ports of Antwerp and Zeebrugge in Belgium. 

Article Topics

certification  |  DEA  |  fingerprint  |  healthcare  |  iBeta  |  Lumidigm